This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Research Reports for Novo Nordisk, Toyota & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Toyota Motor Corporation (TM), and Salesforce, Inc. (CRM).
Stock Market News for Jun 8, 2022
by Zacks Equity Research
U.S. stocks closed higher for the second straight day on Tuesday, led by a rally in tech and energy stocks.
Buy This Tech Stock Down 70% for Long-Term Growth?
by Benjamin Rains
DocuSign shares got super overheated alongside many other pandemic high-flyers and its growth outlook has cooled off after several covid-boosted years. DOCU still, however, operates a business built for the economy of today and tomorrow.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Microsoft Lowers Guidance: ETFs in Focus
by Sweta Killa
The world's largest software maker ¿¿¿ Microsoft (MSFT) ¿¿¿ downgraded its near-term outlook, citing the impact of the strongest U.S. dollar in more than two decades.
Cloud Computing Is One Market That Investors Can't Ignore
by Derek Lewis
Cloud computing is rapidly gaining traction across the globe and is a bright highlight of modern technology. It's allowed businesses and consumers to achieve digital feats that previously felt impossible.
Company News for June 2, 2022
by Zacks Equity Research
Companies in The News Are: FB, CPRI, CRM, HPQ
Is the Options Market Predicting a Spike in Salesforce (CRM) Stock?
by Zacks Equity Research
Investors need to pay close attention to Salesforce (CRM) stock based on the movements in the options market lately.
Salesforce (CRM) Jumps 9% on Q1 Earnings Beat, Guidance Raise
by Zacks Equity Research
A robust demand environment and the rapid adoption of cloud-based solutions and strategic acquisitions result in Salesforce's (CRM) better-than-anticipated Q1 performance.
Markets Lower to Close Out May; CRM Beats in Q1
by Mark Vickery
Both the Dow and S&P have managed to come out slightly positive for the month; the Nasdaq is still down.
Salesforce.com (CRM) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Salesforce.com (CRM) delivered earnings and revenue surprises of 5.38% and 0.54%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
A Welcome Sigh of Relief
by Benjamin Rains
Wall Street seems to expect higher-income consumers to keep spending straight through recession fears and for other shoppers to trade down to store brands and trim other excesses.
Buyout, Digitalization to Boost Salesforce (CRM) Q1 Earnings
by Zacks Equity Research
Salesforce's (CRM) Q1 results are likely to reflect gains from the solid demand for its solutions amid the accelerated digital transformation along with the benefits of acquisitions and partnerships.
What's in the Offing for Salesforce (CRM) This Earnings Season?
by Zacks Equity Research
Though the accelerated digital transformation is likely to have boosted Salesforce's (CRM) Q1 sales, increased investments in sales & marketing and international expansions might have eroded profitability.
Salesforce.com (CRM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $159.65, marking a +1.73% move from the previous day.
Analysts Estimate Salesforce.com (CRM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Salesforce.com (CRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Hold DocuSign (DOCU) Stock in Your Portfolio For Now
by Zacks Equity Research
DocuSign's (DOCU) top line is significantly benefiting from continued customer demand for eSignature.
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $155.60 in the latest trading session, marking a -1.1% move from the prior day.
Stock Market News for May 19, 2022
by Zacks Equity Research
The Dow and the S&P 500 posted their worst plunge in almost two years on Wednesday, as a batch of big-box retailers while announcing their quarterly results cited that rising fuel costs and higher wages are eating into their profits.
The Zacks Analyst Blog Highlights NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce
by Zacks Equity Research
NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce are part of Zacks top Analyst Blog
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Top Analyst Reports for NVIDIA, Home Depot, Pfizer & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), The Home Depot, Inc. (HD), and Pfizer Inc. (PFE).
Salesforce.com (CRM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $160.42, marking a -0.53% move from the previous day.
Salesforce.com (CRM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Salesforce.com (CRM) closed at $177.57, marking a +0.93% move from the previous day.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.